Investor Information - Abzena

Edison Feed

Share Price


Annual Report 2017

Abzena PLC's Annual Report 2017

Business Model – Revenue Generating

Abzena is a revenue generating life sciences group with its headquarters in the UK and two sites in the US. The Group offers a range of complementary services and technologies for the selection, development and manufacture of biopharmaceuticals. These provide two sources of income for the Group:

  • Fee for service income from fixed price and full time equivalent based contracts
  • Technology licence revenues from the development and commercialisation of Abzena inside products – products whose properties have been enhanced with the Group’s proprietary technologies

Read more on Abzena inside

Trading Update

Abzena and OBI Pharma sign ThioBridge™ licence agreement

Antibody manufacturing development agreement signed with UCL

Interested in our services? Get In Touch